On Friday an FDA advisory panel declined to endorseauthorization the Pfizer-BioNTech Covid booster shot for people aged 16 or older.
The panel voted 16-2 to reject extra doses of an experimental vaccine, citing insufficient data from incomplete clinical trials and the potential risk of heart inflammation – especially among young men.